CompletedNot Applicable

A Non-interventional, Observational Study for Targinact® Treatment in Patients With Severe Pain.

Belgium1,338 participantsStarted 2011-04

Plain-language summary

This non-interventional, observational study evaluates the efficacy of Targinact with regard to pain relief in daily clinical practice in Belgium compared to the previous analgesic treatment.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Male or female patients at least 18 years, or older, with severe pain.
✓. Patients with documented history of severe pain treated with WHO step 1, step 2 and/or 3 analgesics with insufficient pain relief and/or unacceptable side effects that require around-the-clock opioid therapy and are likely to benefit from WHO step 3 opioid therapy for the duration of the study.

What they're measuring

To evaluate the efficacy of Targinact® treatment, with regard to pain relief, in patients with severe pain

Timeframe: Up to 140 days

Trial details

NCT IDNCT01983137

SponsorMundipharma CVA

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2012-12

View on ClinicalTrials.gov More Severe Pain trials